Stem Cell Therapy for Autism
Mel Gibson is an actor and filmmaker. Neil Riordan, PA, PhD is one of the early pioneers and experts in applied stem cell research. https://www.cellmedicine.com/
Autism is a spectrum of disorders characterized by marked abnormalities in communication and social interactions. Two common consistent findings are associated in children with this disorder are diminished oxygenation in specific areas of the brain and a chronic immunologically mediated inflammatory condition in the gut. What is the scientific rationale behind using stem cells to treat autism? Current investigative therapies for autism attempt to reverse these abnormalities through administration of antibiotics, anti‐inflammatory agents, and hyperbaric oxygen. Unfortunately, none of these approaches address the root causes of oxygen deprivation and intestinal inflammation. The rationale behind treating autism with umbilical cord tissue-derived mesenchymal stem cells is that autism, and its degree of severity, has been significantly correlated inflammatory and neuro-inflammatory cytokines including macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). Intravenous administration of umbilical cord MSCs has been shown in multiple clinical trials to decrease inflammation. Decreasing inflammation in the autistic patient may alleviate symptoms of autism. Through administration of mesenchymal stem cells, we have observed improvement in patients treated at our facilities.
You need to login or register to bookmark/favorite this content.